ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
77 hedge funds and large institutions have $35.3M invested in Zynerba Pharmaceuticals, Inc in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less call options, than puts
Call options by funds: $1.08M | Put options by funds: $2.15M
Holders
77
Holding in Top 10
–
Calls
$1.08M
Puts
$2.15M
Top Buyers
| 1 | +$505K | |
| 2 | +$383K | |
| 3 | +$319K | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
+$240K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$158K |
Top Sellers
| 1 | -$3.17M | |
| 2 | -$1.61M | |
| 3 | -$797K | |
| 4 |
SC
Sculptor Capital
New York
|
-$556K |
| 5 |
Two Sigma Investments
New York
|
-$420K |